Moreno Ralfh, Nababan Herfina Y, Ota Erika, Wariki Windy M V, Ezoe Satoshi, Gilmour Stuart, Shibuya Kenji
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD003363. doi: 10.1002/14651858.CD003363.pub3.
Community interventions to promote condom use are considered to be a valuable tool to reduce the transmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs). In particular, special emphasis has been placed on implementing such interventions through structural changes, a concept that implies public health actions that aim to improve society's health through modifications in the context wherein health-related risk behavior takes place. This strategy attempts to increase condom use and in turn lower the transmission of HIV and other STIs.
To assess the effects of structural and community-level interventions for increasing condom use in both general and high-risk populations to reduce the incidence of HIV and STI transmission by comparing alternative strategies, or by assessing the effects of a strategy compared with a control.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, from 2007, Issue 1), as well as MEDLINE, EMBASE, AEGIS and ClinicalTrials.gov, from January 1980 to April 2014. We also handsearched proceedings of international acquired immunodeficiency syndrome (AIDS) conferences, as well as major behavioral studies conferences focusing on HIV/AIDS and STIs.
Randomized control trials (RCTs) featuring all of the following.1. Community interventions ('community' defined as a geographical entity, such as cities, counties, villages).2. One or more structural interventions whose objective was to promote condom use. These type of interventions can be defined as those actions improving accessibility, availability and acceptability of any given health program/technology.3. Trials that confirmed biological outcomes using laboratory testing.
Two authors independently screened and selected relevant studies, and conducted further risk of bias assessment. We assessed the effect of treatment by pooling trials with comparable characteristics and quantified its effect size using risk ratio. The effect of clustering at the community level was addressed through intra-cluster correlation coefficients (ICCs), and sensitivity analysis was carried out with different design effect values.
We included nine trials (plus one study that was a subanalysis) for quantitative assessment. The studies were conducted in Tanzania, Zimbabwe, South Africa, Uganda, Kenya, Peru, China, India and Russia, comprising 75,891 participants, mostly including the general population (not the high-risk population). The main intervention was condom promotion, or distribution, or both. In general, control groups did not receive any active intervention. The main risk of bias was incomplete outcome data.In the meta-analysis, there was no clear evidence that the intervention had an effect on either HIV seroprevalence or HIV seroincidence when compared to controls: HIV incidence (risk ratio (RR) 0.90, 95% confidence interval (CI) 0.69 to 1.19) and HIV prevalence (RR 1.02, 95% CI 0.79 to 1.32). The estimated effect of the intervention on other outcomes was similarly uncertain: Herpes simplex virus 2 (HSV-2) incidence (RR 0.76, 95% CI 0.55 to 1.04); HSV-2 prevalence (RR 1.01, 95% CI 0.85 to 1.20); syphilis prevalence (RR 0.91, 95% CI 0.71 to 1.17); gonorrhoea prevalence (RR 1.16, 95% CI 0.67 to 2.02); chlamydia prevalence (RR 0.94, 95% CI 0.75 to 1.18); and trichomonas prevalence (RR 1.00, 95% CI 0.77 to 1.30). Reported condom use increased in the experimental arm (RR 1.20, 95% CI 1.03 to 1.40). In the intervention groups, the number of people reporting two or more sexual partners in the past year did not show a clear decrease when compared with control groups (RR 0.90, 95% CI 0.78 to 1.04), but knowledge about HIV and other STIs improved (RR 1.15, 95% CI 1.04 to 1.28, and RR 1.23, 95% CI 1.07 to 1.41, respectively). The quality of the evidence was deemed to be moderate for nearly all key outcomes.
AUTHORS' CONCLUSIONS: There is no clear evidence that structural interventions at the community level to increase condom use prevent the transmission of HIV and other STIs. However, this conclusion should be interpreted with caution since our results have wide confidence intervals and the results for prevalence may be affected by attrition bias. In addition, it was not possible to find RCTs in which extended changes to policies were conducted and the results only apply to general populations in developing nations, particularly to Sub-Saharan Africa, a region which in turn is widely diverse.
社区层面促进避孕套使用的干预措施被视为减少人类免疫缺陷病毒(HIV)及其他性传播感染(STIs)传播的一项重要手段。特别是,通过结构变革实施此类干预措施受到了特别关注,这一概念意味着旨在通过改变与健康相关的风险行为发生的环境来改善社会健康状况的公共卫生行动。该策略试图增加避孕套的使用,进而降低HIV及其他性传播感染的传播。
通过比较不同策略,或评估某一策略与对照相比的效果,来评估结构层面和社区层面干预措施在普通人群和高危人群中增加避孕套使用以降低HIV及性传播感染发病率的效果。
我们检索了Cochrane对照试验中心注册库(CENTRAL)(《Cochrane图书馆》,2007年第1期),以及MEDLINE、EMBASE、AEGIS和ClinicalTrials.gov,检索时间跨度为1980年1月至2014年4月。我们还手工检索了国际获得性免疫缺陷综合征(AIDS)会议的会议记录,以及聚焦HIV/AIDS和性传播感染的主要行为学研究会议记录。
具备以下所有特征的随机对照试验(RCTs)。1. 社区干预(“社区”定义为一个地理实体,如城市、县、村庄)。2. 一项或多项旨在促进避孕套使用的结构干预措施。这类干预措施可定义为旨在提高任何特定健康项目/技术的可及性、可得性和可接受性的行动。3. 通过实验室检测确认生物学结果的试验。
两位作者独立筛选并选择相关研究,并进行进一步的偏倚风险评估。我们通过合并具有可比特征的试验来评估治疗效果,并使用风险比量化其效应大小。通过组内相关系数(ICCs)处理社区层面的聚类效应,并采用不同的设计效应值进行敏感性分析。
我们纳入了9项试验(加上1项作为亚分析的研究)进行定量评估。这些研究在坦桑尼亚、津巴布韦、南非、乌干达、肯尼亚、秘鲁、中国、印度和俄罗斯开展,涉及75891名参与者,其中大多数为普通人群(而非高危人群)。主要干预措施是避孕套推广、分发或两者兼有。一般而言,对照组未接受任何积极干预。主要的偏倚风险是结局数据不完整。
在荟萃分析中,与对照组相比,没有明确证据表明干预措施对HIV血清阳性率或HIV血清发病率有影响:HIV发病率(风险比(RR)0.90,95%置信区间(CI)0.69至1.19)和HIV患病率(RR 1.02,95%CI 0.79至1.32)。干预措施对其他结局的估计效果同样不确定:单纯疱疹病毒2型(HSV - 2)发病率(RR 0.76,95%CI 0.55至1.04);HSV - 2患病率(RR 1.01,95%CI 0.85至1.20);梅毒患病率(RR 0.91,95%CI 0.71至1.17);淋病患病率(RR 1.16,95%CI 0.67至2.02);衣原体患病率(RR 0.94,95%CI 0.75至1.18);滴虫患病率(RR 1.00,95%CI 0.77至1.30)。试验组报告的避孕套使用有所增加(RR 1.20,95%CI 1.03至1.40)。在干预组中,与对照组相比,过去一年报告有两个或更多性伴侣的人数没有明显减少(RR 0.90,95%CI 0.78至1.04),但对HIV和其他性传播感染的知晓率有所提高(分别为RR 1.15,95%CI 1.04至1.28和RR 1.23,95%CI 1.07至1.41)。几乎所有关键结局的证据质量被认为是中等的。
没有明确证据表明社区层面增加避孕套使用的结构干预措施能预防HIV及其他性传播感染的传播。然而,这一结论应谨慎解读,因为我们的结果置信区间较宽,患病率结果可能受到失访偏倚的影响。此外,未能找到进行了政策长期变革的随机对照试验,且结果仅适用于发展中国家的普通人群,特别是撒哈拉以南非洲地区,而该地区情况又千差万别。